A carregar...

Risk of Hospitalised Bleeding in Comparisons of Oral Anticoagulant Options for the Primary Treatment of Venous Thromboembolism

Understanding of the comparative bleeding risks of oral anticoagulant (OAC) therapies for the primary treatment of venous thromboembolism (VTE) is limited. Therefore, among anticoagulant-naïve VTE patients, we conducted comparisons of apixaban, rivaroxaban and warfarin on the rate of hospitalised bl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Lutsey, Pamela L., Zakai, Neil A., MacLehose, Richard F., Norby, Faye L., Walker, Rob F., Roetker, Nicholas S., Adam, Terrence, Alonso, Alvaro
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536346/
https://ncbi.nlm.nih.gov/pubmed/30919942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15857
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!